Home > Journals > Minerva Pediatrica > Past Issues > Minerva Pediatrica 2017 December;69(6) > Minerva Pediatrica 2017 December;69(6):495-502

CURRENT ISSUE
 

ARTICLE TOOLS

Publication history
Reprints
Cite this article as

MINERVA PEDIATRICA

A Journal on Pediatrics, Neonatology, Adolescent Medicine,
Child and Adolescent Psychiatry


Indexed/Abstracted in: CAB, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 0,764


eTOC

 

ORIGINAL ARTICLE  


Minerva Pediatrica 2017 December;69(6):495-502

DOI: 10.23736/S0026-4946.16.04253-5

Copyright © 2015 EDIZIONI MINERVA MEDICA

language: English

Association of clearance of middle- and large-molecular-weight substance with arterial stiffness and left ventricular mass in children receiving renal replacement therapy

Kadriye ÖZDEMIR 1 , Ebru YILMAZ 1, Nida DINCEL 1, Sibel BOZABALI 2, Sukriye APAYDIN 1, Zubeyr H. GUN 1, Betul SOZERI 1, Sevgi MIR 1

1 Department of Pediatric Nephrology, Ege University School of Medicine, İzmir, Turkey; 2 Department of Pediatric Cardiology, Ege University School of Medicine, İzmir, Turkey


PDF  


BACKGROUND: The prominent cause of mortality in children receiving dialysis treatment is cardiovascular diseases. Risk factors related to chronic renal disease, are effective in the development of cardiovascular diseases. The aim of study was to investigate cardiovascular system (CVS) involvement for functional and structural alterations in children receiving dialysis, and display any association between cardiovascular morbidity and uremic toxins.
METHODS: 20 dialysis patients and 20 healthy controls were included to the study. Clearance of small, middle and large molecular-weight uremic toxins was evaluated in blood samples collected 30 minutes before (D0) and 2 hour after dialysis (D2), and change value was calculated as D0-D2/D0. Cardiovascular involvement was determined by comparing arterial stiffness, carotid intima-media thickness (CIMT) and Left Ventricular Mass Index (LVMI) with the control group.
RESULTS: Four patients receiving hemodialysis and two patients in continuous ambulatory peritoneal dialysis (CAPD) group who have significant differences in all functional and structural parameters were detected. Four dialysis patients with detected cardiovascular disease have distinctively lower beta-2 microglobulin and homocysteine clearances compared to the patients with no CVS involvement.
CONCLUSIONS: The clearance of middle and large molecular-weight substances should be closely monitored in children receiving dialysis.


KEY WORDS: Uremia middle molecule toxins - Cardiovascular system - Renal dialysis

top of page

Publication History

Issue published online: November 22, 2017
Article first published online: April 30, 2015
Manuscript accepted: April 29, 2015
Manuscript revised: April 22, 2015
Manuscript received: January 14, 2015

Cite this article as

Özdemir K, Yilmaz E, Dincel N, Bozabali S, Apaydın S, Gun ZH, et al. Association of clearance of middle- and large-molecular-weight substance with arterial stiffness and left ventricular mass in children receiving renal replacement therapy. Minerva Pediatr 2017;69:495-502. DOI: 10.23736/S0026-4946.16.04253-5

Corresponding author e-mail

kcanturk1@hotmail.com